Your browser doesn't support javascript.
loading
Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial.
Touchefeu, Y; Guimbaud, R; Louvet, C; Dahan, L; Samalin, E; Barbier, E; Le Malicot, K; Cohen, R; Gornet, J M; Aparicio, T; Nguyen, S; Azzedine, A; Etienne, P L; Phelip, J M; Hammel, P; Chapelle, N; Sefrioui, D; Mineur, L; Lepage, C; Bouche, O.
Affiliation
  • Touchefeu Y; Gastrointestinal Oncology Unit, Institut des Maladies de l'Appareil Digestif, University Hospital, 1 place Alexis Ricordeau, 44093, Nantes Cedex 1, France. yann.touchefeu@chu-nantes.fr.
  • Guimbaud R; Digestive Medical Oncology IUCT Rangueil, CHU de Toulouse, Toulouse, France.
  • Louvet C; Oncology Multidisciplinary Research Group (GERCOR), 151 rue du Faubourg Saint Antoine, 75011, Paris, France.
  • Dahan L; Digestive Oncology Unit, AP-HM, La Timone Hospital, Aix-Marseille Université, Marseille, France.
  • Samalin E; Digestive Oncology Department, Institut du Cancer de Montpellier, Montpellier, France.
  • Barbier E; Fédération Francophone de Cancérologie Digestive-EPICAD INSERM LNC-UMR 1231, University of Burgundy and Franche Comté, Dijon, France.
  • Le Malicot K; Fédération Francophone de Cancérologie Digestive-EPICAD INSERM LNC-UMR 1231, University of Burgundy and Franche Comté, Dijon, France.
  • Cohen R; Department of Oncology, Sorbonne Université, AP-HP, hôpital Saint-Antoine, 75012, Paris, France.
  • Gornet JM; Department of Gastroenterology, AP-HP Hôpital Saint Louis, Paris, France.
  • Aparicio T; Department of Gastroenterology and Digestive Oncology, Saint Louis Hospital, APHP, University Denis Diderot, Sorbonne Paris Cité, Paris, France.
  • Nguyen S; Oncology Multidisciplinary Research Group (GERCOR), 151 rue du Faubourg Saint Antoine, 75011, Paris, France.
  • Azzedine A; Department of oncology, CH Montélimar, Montélimar, France.
  • Etienne PL; Oncology Department, CARIO, HPCA, Plérin, France.
  • Phelip JM; Service HGE et Oncologie Digestive, CHU de Saint Etienne, Unité HESPER EA-7425 Université Jean Monnet/Claude Bernard Lyon 1, Villeurbanne, France.
  • Hammel P; Digestive Oncology Unit, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris, Clichy, France.
  • Chapelle N; Gastrointestinal Oncology Unit, Institut des Maladies de l'Appareil Digestif, University Hospital, 1 place Alexis Ricordeau, 44093, Nantes Cedex 1, France.
  • Sefrioui D; Digestive Oncology Unit, Department of Hepato-Gastroenterology, Rouen University Hospital, UNIROUEN, Inserm U1245, IRON group, Normandie University, 76000, Rouen, France.
  • Mineur L; Institut Sainte Catherine, Avignon, France.
  • Lepage C; Gastroenterology Department, INSERM UMR1231, CHU de Dijon, University Bourgogne Franche-Comté, Dijon, France.
  • Bouche O; Digestive Oncology, CHU REIMS, Reims, France.
Gastric Cancer ; 22(3): 577-586, 2019 05.
Article in En | MEDLINE | ID: mdl-30311042

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Esophagogastric Junction Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Gastric Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2019 Document type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Esophagogastric Junction Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Gastric Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2019 Document type: Article Affiliation country: France